Mindful Walking Program for Older African Americans
Evaluation of an Outdoor Mindful Walking Program for Sustaining Cognitive Function in Older African Americans at Risk for Dementia
1 other identifier
interventional
114
1 country
1
Brief Summary
The goal of this clinical trial is to understand the beneficial role of mindful walking in sustaining cognitive health in African American older adults who have elevated risk of developing neuropsychological diseases. The main question it aims to answer is "Does a multi-session mindful walking intervention lead to promising signals of sustaining cognitive health in vulnerable AA older adults?" The researchers in this 2-arm randomized controlled trial will compare the mindful walking group with a delayed mindful walking to see if the intervention efficacy is observed at multiple follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2023
CompletedFirst Submitted
Initial submission to the registry
October 8, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedOctober 16, 2023
October 1, 2023
1.1 years
October 8, 2023
October 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cognitive Function as assessed by the Montreal Cognitive Assessment (MoCA)
MoCA is a rapid screening instrument for mild cognitive dysfunction. It assesses different cognitive domains: attention and concentration, executive functions, memory, language, conceptual thinking, calculations, and orientation.
Baseline, 12,18,24 weeks follow-up
Everyday Cognition as assessed by the NIH Mobile Toolbox
The NIH Mobile Toolbox is a smartphone-based, ultra-brief cognitive assessments to measure different domains of cognition using the smartphone screen.
Baseline, 18, 24 weeks follow-up (4 days each), Weeks 12 and 13 (14 days)
Secondary Outcomes (9)
Perceived Quality of Life as assessed by the EuroQol 5 dimensions and 5 levels questionnaire
Baseline, 12,18,24 weeks follow-up
Subjective Physical Activity Levels as assessed by the CHAMPS (Community Health Activities Model Program for Seniors) questionnaire
Baseline, 12,18,24 weeks follow-up
Device-based Physical Activity Levels as assessed by the activPAL Accelerometer
Weeks 12 and 13 (14 days)
Mindfulness Level as assessed by the Mindfulness Attention Awareness Scale and Five Facet Mindfulness Questionnaire
Baseline, 12,18,24 weeks follow-up
Overall Health Status as assessed by the SF-36 self-report survey
Baseline, 12,18,24 weeks follow-up
- +4 more secondary outcomes
Other Outcomes (10)
Height as measured from the top of the person's head to the heel using digital stadiometer
Baseline
Weight as measured using a digital floor scale
Baseline
Body Mass Index (BMI) as calculated by the height and weight measures
Baseline
- +7 more other outcomes
Study Arms (2)
Mindful walking
EXPERIMENTALComplete a 24-session outdoor mindful walking intervention over 3 months
Delayed mindful walking group
OTHEROption to complete a delayed 24-session mindful walking
Interventions
Participate in 24 sessions of outdoor mindful walking on a local walking trail over three months
Eligibility Criteria
You may qualify if:
- African American ages 60 and above
- Mild symptoms of cognitive decline or MCI
- Physically inactive or insufficiently active (based on the 2018 US guidelines)
- Adequate hearing and visual ability to complete study tasks and assessments
- English proficiency
- Medically stable with or without medication
- Capable of providing informed consent
- Willing to be randomized to one of the two groups
You may not qualify if:
- Clinical diagnosis of ADRD or other brain abnormalities (e.g., strokes, epilepsy, Parkinson's disease
- Clinical diagnosis of psychiatric disorders (i.e., depression, post-traumatic stress disorder, bipolar disorder)
- Unable to walk independently (i.e., need caregiver's assistance) 4) Plan to have surgery or relocate outside the area within the next 6 months
- \) Currently participate in other studies involving physical activity, mindfulness, or cognitive training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of South Carolina
Columbia, South Carolina, 29208, United States
Related Publications (1)
Yang CH, Lee J, Wilcox S, Rudisill AC, Friedman DB, Hakun JG, Neils-Strunjas J, Wei J, Miller MC, Byers MD. Implementation and evaluation of a community-based mindful walking randomized controlled trial to sustain cognitive health in older African Americans at risk for dementia. BMC Geriatr. 2024 Jul 4;24(1):579. doi: 10.1186/s12877-024-05090-2.
PMID: 38965464DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chih-Hsiang "Jason" Yang, PhD
University of South Carolina
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 8, 2023
First Posted
October 16, 2023
Study Start
May 16, 2023
Primary Completion
June 15, 2024
Study Completion
September 30, 2025
Last Updated
October 16, 2023
Record last verified: 2023-10